Icahn Enterprises L.P. (IEP)
Valuation Overview•Is Icahn Enterprises L.P. Overvalued or Undervalued?
Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
Fragile underlying quality score of 28/100; weak margins or elevated debt leverage warrant caution.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, anchored by a strong, well-covered dividend yield.
IEP struggles with subpar profitability and pressured margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company is facing top-line contraction (-13.3% 3Y CAGR) paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 6.8%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | -7.5% | -13.3% | +7.1% | -4.6% | |
| EBITDA | $0.00 | — | -25.6% | — | — | |
| Net Income | -$612.0M | +32.8% | -17.9% | — | +12.9% | |
| EPS (Diluted) | $-1.06 | +44.7% | — | — | +25.0% | |
| Free Cash Flow | $283.0M | -218.5% | — | -1.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 13.1% | 11.5% | 13.7% | 12.5% |
| Operating Margin | 6.8% | 3.6% | 5.2% | 1.3% |
| Net Margin | -4.8% | -4.3% | -3.8% | -1.8% |
| FCF Margin | -1.0% | 9.1% | 6.5% | -0.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.10 | $-0.71 | -810.0% | ||
| Q1'26 | $0.17 | $0.00 | -99.1% | ||
| Q4'25 | $0.14 | $0.49 | +250.0% | ||
| Q3'25 | $0.14 | $-0.30 | -314.3% | ||
| Q2'25 | $0.19 | $-0.79 | -515.8% | ||
| Q1'25 | $0.17 | $-0.19 | -211.8% | ||
| Q4'24 | $0.21 | $0.05 | -76.2% | ||
| Q3'24 | $0.19 | $-0.72 | -478.9% |
Total return is +13.5% (1Y), lagging the benchmark by -7.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +10.0% | +2.7% | — |
| 1Y | +13.5% | -7.3% | +24.6% |
| 3YCAGR | -16.1% | -36.2% | +31.9% |
| 5YCAGR | -10.9% | -22.4% | +43.4% |
| 10YCAGR | +2.4% | -11.6% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Icahn Enterprises L.P. (IEP) valuation, health, and returns.
Icahn Enterprises L.P. is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Limited: Cheap versus peers compared to industry peers. undervalued (implying +280.8% upside to DCF intrinsic value of $27.42)
Icahn Enterprises L.P. has multiple valuation anchors: DCF Intrinsic Value: $27.42 | Peer Relative Fair Value: $16.31. A convergence of these signals offers higher conviction.
Icahn Enterprises L.P. displays weak financial health with a composite quality score of 28/100, supported by a Altman Z-Score of 0.8 (distress zone), Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of -0.0%.
Icahn Enterprises L.P. pays a 7.0% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 0.0% buyback yield.
Icahn Enterprises L.P.'s current growth trajectory is Accelerating. The company achieved -7.5% 1Y revenue growth and +44.7% 1Y EPS growth, compared to its 3Y revenue CAGR of -13.3%.
Wall Street consensus is Buy based on 2 analysts, beating EPS expectations in 8% of recent quarters with a -2-quarter streak. The consensus price target represents a N/A change from current levels.
Investment risks for Icahn Enterprises L.P. include: -25.6% 1-year max drawdown, elevated distress risk. Volatility risk is characterized by a beta of 0.45x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.